AI summary by TwinMind

Insulin Prices Have Skyrocketed. Here’s How California Aims to Change That. | WSJ

The Wall Street Journal

7m 54s

California's Insulin Manufacturing Initiative

  • Governor Gavin Newsom announced first-in-nation plan for California to manufacture its own insulin
  • State allocating $100 million in budget:
    • $50 million to develop low-cost insulin
    • $50 million to establish in-state manufacturing facility
  • State involvement eliminates profit motive, enabling very low-cost production
  • Governor's office projects cost reduction from $300-500/month to at minimum half that amount
  • Full details not announced including availability timeline and exact pricing

Current Insulin Market Crisis

  • Americans pay ~8x more for insulin than rest of developed world
  • 2020 Medicare Part D average out-of-pocket: $54 per prescription
  • Essential medication for 7.4 million diabetic Americans (~2% of US population)
  • Discovered 1921, life-saving drug for Type 1 diabetes which was previously often fatal

Market Structure Problems

  • Three manufacturers control almost 100% of US insulin supply
  • Complex manufacturing process with less established regulatory pathway for biosimilar competition
  • Limited competition due to regulatory barriers
  • All supply chain entities are for-profit with fiduciary responsibility to shareholders, not patients

Pricing Complexity and Middlemen Issues

  • List price vs. net price discrepancy:
    • 2019 Sanofi example: average list price $361, net price $62
  • Pharmacy Benefit Managers (PBMs) identified as contributing factor in 2021 Senate investigation
  • PBMs negotiate between manufacturers, insurance companies, and pharmacies
  • Manufacturers pay discounts, rebates, coupons, fees back through distribution system
  • Net price = list price minus all discounts/rebates/fees
  • Sanofi claims net insulin prices fallen for seven consecutive years

Alternative Models Emerging

Mark Cuban Cost Plus Drug Company

  • Launched earlier in 2022
  • Online store selling hundreds of low-cost generic medications
  • Model undercuts traditional supply chain by selling directly to consumers
  • Eliminates PBMs from process

Civica Rx Non-Profit Model

  • Established by hospitals and philanthropic groups
  • Healthcare utility model with membership structure
  • Hospital systems partner to purchase generic drugs
  • Launched September 2018, now producing 64 generic drugs
  • Building 140,000 sq ft manufacturing facility in Petersburg, Virginia
  • Plans insulin production by early 2024
  • Pricing commitment: max $30/vial, $55 for 5-pen cartridges
  • Will manufacture three generic insulins in vials and pre-filled pens
  • Facility capable of 100% vial capacity for entire country
  • Only enters markets with distortion/failure, avoids well-functioning markets

Federal Policy Response

  • President Biden signed prescription drug price legislation August 16th
  • Medicare insulin costs capped at $35/month starting next year
  • Biden noted 18-month anticipation of this action

Industry Responses

  • Novo Nordisk: developing programs to ensure diabetes patients get needed insulin
  • Eli Lilly: committed to affordability, advocates passing rebates directly to patients and limiting out-of-pocket costs
  • Sanofi: emphasizes net price reductions over seven years, notes PBM rebate demands ingrained in healthcare system

Market Impact Projections

  • Introduction of low-cost alternatives would force established players to accept lower profit margins
  • California's non-profit approach could significantly disrupt current pricing structure

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome